Insmed Reports Fourth Quarter and Full Year 2021 Financial …
https://investor.insmed.com/2022-02-17-Insmed-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-Business-and-Pipeline-Update
WebFeb 17, 2022 · Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States , Europe , and Japan to treat a chronic, debilitating lung disease.
DA: 27 PA: 42 MOZ Rank: 12 Up or Down: Up